Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Plos One
|
December 3, 2015
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
Marius M Hoeper, Juergen Behr, Matthias Held, et al.
The European Respiratory Journal
|
May 9, 2020
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Jürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Respiratory Research
|
March 17, 2019
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
Michael Kreuter, Jeff Swigris, David Pittrow, et al.
Nature
|
March 26, 2026
Decadal-scale droughts disrupted the African Humid Period in the Sahara
Florence Sylvestre, Martin Melles, Volker Wennrich, et al.
Respiratory Research
|
July 16, 2017
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
Michael Kreuter, Jeff Swigris, David Pittrow, et al.
The Lancet. Respiratory Medicine
|
April 2, 2021
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
Jürgen Behr, Antje Prasse, Michael Kreuter, et al.
The European Respiratory Journal
|
April 4, 2015
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Jürgen Behr, Michael Kreuter, Marius M Hoeper, et al.
Chest
|
February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
Circulation
|
October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
ERJ Open Research
|
January 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysis
Jürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Plos One
|
December 3, 2015
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
Marius M Hoeper, Juergen Behr, Matthias Held, et al.
The European Respiratory Journal
|
May 9, 2020
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Jürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Respiratory Research
|
March 17, 2019
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
Michael Kreuter, Jeff Swigris, David Pittrow, et al.
Nature
|
March 26, 2026
Decadal-scale droughts disrupted the African Humid Period in the Sahara
Florence Sylvestre, Martin Melles, Volker Wennrich, et al.
Respiratory Research
|
July 16, 2017
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
Michael Kreuter, Jeff Swigris, David Pittrow, et al.
The Lancet. Respiratory Medicine
|
April 2, 2021
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
Jürgen Behr, Antje Prasse, Michael Kreuter, et al.
The European Respiratory Journal
|
April 4, 2015
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Jürgen Behr, Michael Kreuter, Marius M Hoeper, et al.
Chest
|
February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
Circulation
|
October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
ERJ Open Research
|
January 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysis
Jürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Page
of 5